The effect of 300 mW, 830 nm laser on chronic neck pain  by Sterling, Michele & Maher, Chris
Australian Journal of Physiotherapy 2006  Vol. 52  –   © Australian Physiotherapy Association 2006302
Appraisal Critically Appraised Papers
Summary of: Chow RT, Heller GZ, Barnsley L (2006) The 
effect of 300 mW, 830 nm laser on chronic neck pain: a 
double-blind, randomised, placebo-controlled study. Pain 
124: 201–210. [Prepared by Julia Hush, CAP Editor.]
Question: Does 300 mW, 830 nm low-level laser therapy 
(LLLT) improve pain, disability and quality of life in people 
with chronic neck pain? Design: Randomised controlled 
trial. Setting: Primary care (medical centre of 17 general 
practitioners). Participants: Ninety subjects with chronic 
neck pain (mean duration 15.1 + 12.6 years). Interventions: 
The intervention group received twice-weekly treatments of 
LLLT (830 nm, 300 mW, at a power density of 0.67 W/
cm2) applied to tender points in the neck, for 7 weeks. The 
control group received sham laser treatment. Outcomes: 
The primary outcome was pain intensity (10 cm VAS 
scale). Other outcomes were quality of life (Short Form-
36, consisting of a Physical Component Summary and 
a Mental Component Summary, each scored from 0 to 
100); perceived disability (Northwick Park Neck Pain 
Questionnaire, NPNPQ, measured on a scale of 0 to 36); 
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neck pain intensity and interference with living (Neck Pain 
and Disability Scale, NPAD, measured on a scale of 0 to 
100); pain (Short-Form McGill Pain Questionnaire, MPQ) 
and a participant rating of global assessment (self-assessed 
improvement, SAI, expressed as percentage change). 
Outcomes were measured 1 month after completion of the 
treatment (approximately 12 weeks from baseline). Results: 
The between-group difference in VAS pain score at 12 
weeks was –3.0 cm (95% CI –2.1 to –3.8). Measured on the 
McGill VAS Pain Scale, the reduction in pain intensity was 
–2.2 cm (95% CI –0.9 to –3.5). Self-assessed improvement 
(SAI) scores favoured the active LLLT group, with between 
group differences of 41% (95% CI 27.7 to 55.8). The NPAD 
disability score was reduced by a mean of –12.1 (95% CI 
–19.3 to –4.8). The mean change in NPNPQ score was –3.0 
(95% CI –5.0 to –9.0). Negligible changes (3% to 5%) were 
reported in the SF-36 and MPQ (sensory and affective) 
scores. Conclusion: LLLT, as implemented in this study, 
was effective in providing pain relief for patients with 
chronic neck pain.
Commentary 1
As stated by the authors of this paper, neck pain is a highly 
prevalent condition that incurs significant economic and 
personal costs. Evidence for the efficacy of physical treatment 
interventions is not strong and studies investigating such 
interventions are needed urgently.
This randomised, placebo-controlled trial investigated 
the effect of low level laser therapy (LLLT) on pain, 
disability, and quality of life in patients with chronic neck 
pain. The results demonstrated 300 mW, 800 nm LLLT to 
be effective in reducing pain measured on a VAS scale. 
There was also improvement on secondary outcomes of 
disability and superior self-perceived global improvement 
compared to placebo. The results of this study would appear 
to be clinically relevant with changes on both the pain 
and disability measures exceeding documented minimal 
clinically-important differences (Hagg et al 2003, Leak et 
al 1994). However it should be noted that the follow-up 
was three months post baseline assessment and longer term 
effects are unknown.
The LLLT was delivered to palpably allodynic areas of the 
cervical and thoracic regions twice-weekly for seven days. 
With calls for more multimodal approaches to management, 
it may be difficult for most physiotherapists to reconcile 
such a monomodal treatment approach. It would, therefore, 
be interesting to determine the possible additive effect of 
LLLT to other interventions, for example exercise therapy.
Based on previous animal studies, the authors propose some 
interesting hypotheses for potential mechanisms underlying 
their findings, including the reduction of peripheral 
nociceptive input to the dorsal horn and subsequent pain 
modulation in the CNS. The authors acknowledge that 
investigation of subgroups of neck pain rather than ‘lumping’ 
together people with a variety of underlying mechanisms 
may be a future approach. This would seem especially 
prudent for neck pain where subgroups have been identified 
based on presentations indicative of varying pain processing 
mechanisms. This includes a group of neck pain patients, 
with apparent augmented central pain processing changes, 
that shows recalcitrance to physiotherapy interventions 
(Scott et al 2005). The effect of LLLT in this patient group 
would be an interesting investigation.
Overall this study indicates that LLLT is useful in decreasing 
pain and disability of chronic neck pain, in the medium 
term. Further studies are warranted to explore more long 
term effects, additive effects with other interventions, and 
differential effects in identified neck pain sub-groups.
Michele Sterling 
The University of Queensland, Australia
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Commentary 2
A between-group difference of 3 points on a 10 point pain 
scale is an enormous effect and rarely seen in trials evaluating 
physical treatment for spinal pain. Clinicians reading this 
result may be tempted to apply laser to their patients. One 
difficulty is that other laser trials have produced the opposite 
result with laser no better than a sham. Advocates of laser 
explain these contradictions as arising from the use of 
different doses of laser but they may equally have arisen 
from differences in trial design.
A key design feature is blinding. Trials with inadequate 
blinding tend to show a greater effect of intervention (Schulz 
et al 1995). In the Chow trial the method of blinding was not 
robust. The two laser units were labelled A and B with only 
one emitting a laser beam. The authors reported that they 
achieved blinding by requiring therapist and patients to don 
protective goggles during treatment. While this method of 
blinding is better than simply asking people to close their 
eyes or look away, the potential for unblinding is obvious. 
Importantly the trial did not assess patient blinding beyond 
the first treatment and never assessed therapist blinding, so 
the extent of this potential problem is unclear.
Until this result is replicated in larger trials with more 
robust blinding I would advise caution with regard to the 
use of laser in the treatment of chronic neck pain. There are 
other treatment options for this condition that have more 
convincing support from clinical trials.
Chris Maher 
The University of Sydney, Australia
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